| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:hACC2-IN-1
CAS:192323-14-1
Package:25mg/RMB 10600;50mg/RMB 13800;100mg/RMB 17500
|
Carbamic acid, N-[[trans-4-[[(2-naphthalenylsulfonyl)amino]methyl]cyclohexyl]methyl]-, 1,1-dimethylethyl ester manufacturers
- hACC2-IN-1
-
- $1520.00 / 25mg
-
2025-10-27
- CAS:192323-14-1
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Carbamic acid, N-[[trans-4-[[(2-naphthalenylsulfonyl)amino]methyl]cyclohexyl]methyl]-, 1,1-dimethylethyl ester Basic information |
| | Carbamic acid, N-[[trans-4-[[(2-naphthalenylsulfonyl)amino]methyl]cyclohexyl]methyl]-, 1,1-dimethylethyl ester Chemical Properties |
| density | 1.161±0.06 g/cm3(Predicted) | | pka | 11.39±0.40(Predicted) |
| | Carbamic acid, N-[[trans-4-[[(2-naphthalenylsulfonyl)amino]methyl]cyclohexyl]methyl]-, 1,1-dimethylethyl ester Usage And Synthesis |
| Uses | hACC2-IN-1 is a potent acetyl-CoA carboxylase 2 (ACC2) inhibitor, with an IC50 value of 2.5 μM (hACC2). hACC2-IN-1 could be used for obesity research[1]. | | IC 50 | hACC2: 2.5 μM (IC50) | | References | [1] Bengtsson C, et al. Design of small molecule inhibitors of acetyl-CoA carboxylase 1 and 2 showing reduction of hepatic malonyl-CoA levels in vivo in obese Zucker rats. Bioorg Med Chem. 2011 May 15;19(10):3039-53. DOI:10.1016/j.bmc.2011.04.014 |
| | Carbamic acid, N-[[trans-4-[[(2-naphthalenylsulfonyl)amino]methyl]cyclohexyl]methyl]-, 1,1-dimethylethyl ester Preparation Products And Raw materials |
|